Hydromed

Hydrochlorothiazide, the active ingredient in Hydromed, is a thiazide diuretic presented as an oral tablet for oral use. It is employed to lower high blood pressure and to reduce fluid retention in patients with edema. By promoting the excretion of sodium and water, it helps control cardiovascular strain and supports overall fluid balance.

GNH USA supplies Hydromed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare institutions worldwide.

Hydrochlorothiazide is a thiazide diuretic used to manage conditions related to excess fluid and high blood pressure. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Edema: decreases peripheral fluid accumulation associated with heart, liver or kidney disease. - Congestive heart failure: assists in relieving volume overload when combined with other heart‑failure therapies.

Hydrochlorothiazide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased urination: frequent need to void. - Dizziness or light‑headedness: especially after standing. - Electrolyte disturbances: low potassium or sodium levels. - Headache: mild to moderate intensity. - Elevated blood glucose: transient rise in blood sugar. - Gout flare: increased uric acid concentration.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Blood disorders: agranulocytosis or thrombocytopenia. - Pancreatitis: abdominal pain with elevated enzymes. - Hepatic dysfunction: jaundice or abnormal liver tests.

When prescribing Hydrochlorothiazide, clinicians should consider several precautionary measures to ensure patient safety. - Monitor electrolytes: regular blood tests to detect sodium, potassium, and magnesium changes. - Assess renal function: evaluate kidney performance before and during therapy. - Use caution in gout: may increase uric acid levels and precipitate attacks. - Avoid in severe hepatic impairment: limited metabolism may raise drug exposure. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Hydrochlorothiazide can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity due to reduced clearance. - Cyclosporine: increased nephrotoxicity when combined. - NSAIDs: may diminish diuretic efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors: additive hypotensive effect, monitor blood pressure. - Antidiabetic drugs: may enhance hypoglycemic action, adjust dosage as needed. - Beta‑blockers: combined blood‑pressure lowering may require careful titration.